Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Allergic Rhinitis Market Grown from 2024 to 2025?

In recent times, the market size of allergic rhinitis has been witnessing a stable rise. The size of the market which stands at $15.22 billion in 2024, is predicted to escalate to $15.74 billion in 2025, marking a compound annual growth rate (CAGR) of 3.4%. Factors such as exposure to allergens, shifts in the environment, heightened public consciousness, escalating pollution levels, advances in allergic rhinitis research, and increasing disposable incomes have contributed to the growth observed during the historic period.

What Growth Rate Is Anticipated for the Allergic Rhinitis Market in the Coming Years?

It is predicted that the market for allergic rhinitis will experience consistent expansion in the upcoming years, reaching a value of $18.49 billion in 2029 with a 4.1% Compound Annual Growth Rate (CAGR). Factors that will drive growth during this forecasting period include the need for preventive therapies, an aging population, urbanization, and health care expenditures. Noteworthy trends for this projection period includes the prevalence of biologics and monoclonal antibodies, digital health initiatives, strategies for allergen avoidance, treatment for pediatric allergic rhinitis, and allergen identification technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

Who Are the Leading Companies in the Allergic Rhinitis Market?

Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.

What Are the Key Drivers of the Allergic Rhinitis Market?

Projected growth within the allergic rhinitis market is expected to be fueled by high levels of air pollution and the ongoing changes in climate. When harmful substances inhabit the atmosphere of our planet, this constitutes air pollution. This can have detrimental effects on human health, the state of our environment and the quality of the air we inhale. Similarly, climate change denotes the long-term shifts in Earth’s climatic conditions, such as temperature, precipitation and other climate factors. The link between air pollution and the increasing incidence and exacerbation of allergic rhinitis has been recognized, highlighting the complex interplay between air quality and respiratory health. As a case in point, the United States Environmental Protection Agency reported in August 2024 that in 2023, some 66 million tons of pollutants had been discharged into the air across the United States. Consequently, the growth of the allergic rhinitis market is being driven by high levels of air pollution and climate change.

Allergic Rhinitis Market Influencer: Rising Use of Corticosteroid Treatment Bolsters Allergic Rhinitis Market Growth

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12926&type=smp

What Are the Key Market Segments in the Allergic Rhinitis Industry?

The allergic rhinitis market covered in this report is segmented –

1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis

2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments

3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count

4) By Route Of Administration: Oral, Nasal, Other Route Of Administration

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores

Subsegments:

1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy

2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy

3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens

What Are the Latest Trends in the Allergic Rhinitis Market?

Leading businesses in the allergic rhinitis market are introducing revolutionary drugs in order to maintain their market standing. For instance, Hikma Pharmaceuticals PLC, a pharmaceutical firm based in the UK, and Glenmark Specialty S.A., a pharmaceutical company headquartered in Switzerland, received approval from the United States Food and Drug Administration (FDA), a federal agency in the US, for their product Ryaltris in August 2022. Ryaltris is the inaugural fixed-dose combination medication designed to alleviate both nasal and ocular symptoms of seasonal allergic rhinitis, distributed in an easy-to-use nasal spray for adults and pediatric patients aged 12 and above. The nasal symptoms start to diminish just 15 minutes after administering the initial dose.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

What Are the Key Regional Markets in the Allergic Rhinitis Industry?

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12926

This Report Delivers Insight On:

1. How big is the allergic rhinitis market, and how is it changing globally?

2. Who are the major companies in the allergic rhinitis market, and how are they performing?

3. What are the key opportunities and risks in the allergic rhinitis market right now?

4. Which products or customer segments are growing the most in the allergic rhinitis market?

5. What factors are helping or slowing down the growth of the allergic rhinitis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model